Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
fda
2
×
life sciences
national blog main
biotech ipos
boston
boston blog main
boston top stories
clinical trials
deals
dyne therapeutics
food and drug administration
medical device
metacrine
myotonic dystrophy type 1
nonalcoholic steatohepatitis
pulmonary arterial hypertension
raleigh-durham blog main
rare disease drugs
rare diseases
salk institute
san diego blog main
san diego top stories
san francisco
san francisco blog main
san francisco top stories
startups
steadymed
treprostinil
ulcerative colitis
united therapeutics
What
drug
rare
2
×
therapeutics
brings
building
company
deal
developer
developing
disease
disorders
dyne
dyne’s
established
firm
genetic
ipo
lung
medicines
million
momentum
muscle
muscular
pah
preclinical
raised
reaches
rivalry
seller
stage
steadymed
therapy
topped
united
upsized
Language
unset
Current search:
rare
×
biotech
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed